NYSE:ELAN Elanco Animal Health (ELAN) Stock Price, News & Analysis $20.84 +1.04 (+5.25%) Closing price 03:59 PM EasternExtended Trading$21.10 +0.27 (+1.27%) As of 07:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Elanco Animal Health Stock (NYSE:ELAN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Elanco Animal Health alerts:Sign Up Key Stats Today's Range$19.85▼$21.1150-Day Range$19.78▼$26.2152-Week Range$12.40▼$27.72Volume8.00 million shsAverage Volume5.35 million shsMarket Capitalization$10.41 billionP/E RatioN/ADividend YieldN/APrice Target$28.20Consensus RatingModerate Buy Company Overview Elanco Animal Health Inc. is a global leader in animal health dedicated to improving food and companion animal well-being. The company develops, manufactures and markets a range of products, including parasiticides, vaccines, antibiotics and feed additives designed to prevent and treat disease in livestock and pets. Elanco’s portfolio spans both food-producing animals—such as cattle, swine, poultry and aquaculture—and companion animals, with offerings that support parasite control, pain management and infectious disease prevention. Originally founded as the animal health division of Eli Lilly and Company in the mid-20th century, Elanco was spun off into an independent publicly traded company in 2018. Since then, Elanco has pursued strategic acquisitions to strengthen its global footprint and expand its R&D capabilities. A notable milestone was the 2020 acquisition of Bayer’s Animal Health business, which added complementary products and bolstered Elanco’s presence across Europe, Latin America, Asia-Pacific and North America. Elanco operates a network of research centers, manufacturing sites and distribution facilities around the world, enabling it to serve customers in more than 90 countries. The company invests in collaborations with universities, industry partners and veterinarians to advance its pipeline of biologics and pharmaceuticals. Under the leadership of President and Chief Executive Officer Jeffrey Simmons, Elanco continues to focus on innovation, sustainability and responsible use of medicines to address emerging health challenges in animal agriculture and companion care.AI Generated. May Contain Errors. Read More Elanco Animal Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks92nd Percentile Overall ScoreELAN MarketRank™: Elanco Animal Health scored higher than 92% of companies evaluated by MarketBeat, and ranked 183rd out of 851 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.4 / 5Analyst RatingModerate Buy Consensus RatingElanco Animal Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.77, and is based on 1 strong buy rating, 9 buy ratings, 2 hold ratings, and 1 sell rating.Upside PotentialElanco Animal Health has a consensus price target of $28.20, representing about 35.3% upside from its current price of $20.84.Amount of Analyst CoverageElanco Animal Health has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Elanco Animal Health's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth9.01% Earnings GrowthEarnings for Elanco Animal Health are expected to grow by 9.01% in the coming year, from $1.11 to $1.21 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Elanco Animal Health is -41.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Elanco Animal Health is -41.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioElanco Animal Health has a PEG Ratio of 2.14. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioElanco Animal Health has a P/B Ratio of 1.60. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Elanco Animal Health's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.93% of the float of Elanco Animal Health has been sold short.Short Interest Ratio / Days to CoverElanco Animal Health has a short interest ratio ("days to cover") of 5.82.Change versus previous monthShort interest in Elanco Animal Health has recently decreased by 0.90%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldElanco Animal Health does not currently pay a dividend.Dividend GrowthElanco Animal Health does not have a long track record of dividend growth. News and Social Media4.1 / 5News Sentiment0.49 News SentimentElanco Animal Health has a news sentiment score of 0.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Elanco Animal Health this week, compared to 6 articles on an average week.Search Interest11 people have searched for ELAN on MarketBeat in the last 30 days. This is an increase of 450% compared to the previous 30 days.MarketBeat Follows5 people have added Elanco Animal Health to their MarketBeat watchlist in the last 30 days. This is an increase of 67% compared to the previous 30 days. Company Ownership3.6 / 5Insider TradingAcquiring Shares Cluster Insider Buying2 insiders have purchased shares of Elanco Animal Health in the last three months. Multiple insiders buying is a strong bullish signal.Net Insider BuyingOver the last three months, insiders have purchased a net $199,806.00 in company stock, which represents 0.0019% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Elanco Animal Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $199,806.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders1.14% of the stock of Elanco Animal Health is held by insiders.Percentage Held by Institutions97.48% of the stock of Elanco Animal Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Elanco Animal Health's insider trading history. Receive ELAN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Elanco Animal Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ELAN Stock News HeadlinesJeffrey Simmons Acquires 4,971 Shares of Elanco Animal Health (NYSE:ELAN) StockMay 20 at 6:49 AM | insidertrades.comElanco Launches Befrena™ (tirnovetmab), New Anti-IL-31 Monoclonal Antibody, a Breakthrough Addition to the $1.3 Billion U.S. Canine Dermatology MarketMay 18 at 7:27 AM | prnewswire.comTrump Is Eyeing the Biggest Monetary Shift Since NixonOn August 15, 1971, Nixon ended the Bretton Woods agreement and untethered the dollar from gold. Since that night, the dollar has lost over 85% of its purchasing power - and retirement savers have absorbed the cost. U.S. Code Title 31, Section 5117 gives the Treasury authority to reprice America's gold reserves from $42 per ounce to today's market value - a gap of 107x. More than 60 million Americans can move into physical gold inside a retirement account, tax-free and penalty-free.May 20 at 1:00 AM | Americas Gold Company (Ad)Elanco Animal Health, Inc.May 17 at 9:47 AM | edition.cnn.comMorgan Stanley Reaffirms Their Hold Rating on Elanco Animal Health (ELAN)May 16, 2026 | theglobeandmail.comWall Street Zen Upgrades Elanco Animal Health (NYSE:ELAN) to Strong-BuyMay 16, 2026 | americanbankingnews.comElanco to Participate in Upcoming Investor ConferencesMay 14, 2026 | prnewswire.com5 insightful analyst questions from Elanco’s Q1 earnings callMay 13, 2026 | msn.comSee More Headlines ELAN Stock Analysis - Frequently Asked Questions How have ELAN shares performed this year? Elanco Animal Health's stock was trading at $22.64 at the beginning of the year. Since then, ELAN stock has decreased by 8.0% and is now trading at $20.84. How were Elanco Animal Health's earnings last quarter? Elanco Animal Health Incorporated (NYSE:ELAN) announced its quarterly earnings results on Wednesday, May, 6th. The company reported $0.40 earnings per share for the quarter, topping analysts' consensus estimates of $0.34 by $0.06. Elanco Animal Health's revenue for the quarter was up 14.9% on a year-over-year basis. Read the conference call transcript. When did Elanco Animal Health IPO? Elanco Animal Health (ELAN) raised $1.4 billion in an initial public offering (IPO) on Thursday, September 20th 2018. The company issued 62,900,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Barclays, BNP PARIBAS, BofA Merrill Lynch, Citigroup, Credit Suisse, Deutsche Bank Securities, Evercore ISI, Cowen, Academy Securities, Drexel Hamilton, Mischler Financial Group, Ramirez and The Williams Capital Group were co-managers. Who are Elanco Animal Health's major shareholders? Elanco Animal Health's top institutional shareholders include Dimensional Fund Advisors LP (4.93%), The Manufacturers Life Insurance Company (1.25%), Sei Investments Co. (1.13%) and Bank of New York Mellon Corp (0.77%). Insiders that own company stock include R David Hoover, Jeffrey N Simmons, Rajeev A Modi, Lawrence Erik Kurzius, Robert M Vanhimbergen and Michael J Harrington. View institutional ownership trends. How do I buy shares of Elanco Animal Health? Shares of ELAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Elanco Animal Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Elanco Animal Health investors own include Salesforce (CRM), Home Depot (HD), Chevron (CVX), Pfizer (PFE), Bank of America (BAC), Qualcomm (QCOM) and AbbVie (ABBV). Company Calendar Last Earnings5/06/2026Today5/20/2026AGM 20265/21/2026Stifel Jaws & Paws Conference 20265/27/202646th Annual William Blair Growth Stock Conference6/02/2026Next Earnings (Estimated)8/06/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (1w+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 For the last 9 days, ELAN's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED - OUTP/HM CRE Sub-IndustryPharmaceutical Products Current SymbolNYSE:ELAN CIK1739104 Webwww.elanco.com Phone(877) 352-6261FaxN/AEmployees9,400Year Founded1954Price Target and Rating Average Price Target for Elanco Animal Health$28.20 High Price Target$31.00 Low Price Target$23.00 Potential Upside/Downside+35.3%Consensus RatingModerate Buy Rating Score (0-4)2.77 Research Coverage13 Analysts Profitability EPS (Trailing Twelve Months)($0.50) Trailing P/E RatioN/A Forward P/E Ratio18.77 P/E Growth2.14Net Income-$232 million Net Margins-4.95% Pretax Margin-4.03% Return on Equity7.42% Return on Assets3.66% Debt Debt-to-Equity Ratio0.60 Current Ratio2.16 Quick Ratio1.12 Sales & Book Value Annual Sales$4.89 billion Price / Sales2.13 Cash Flow$2.43 per share Price / Cash Flow8.59 Book Value$13.01 per share Price / Book1.60Miscellaneous Outstanding Shares499,450,000Free Float493,756,000Market Cap$10.41 billion OptionableOptionable Beta1.69 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (NYSE:ELAN) was last updated on 5/20/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredTrump Is Eyeing the Biggest Monetary Shift Since NixonOn August 15, 1971, Nixon ended the Bretton Woods agreement and untethered the dollar from gold. Since that ni...Americas Gold Company | SponsoredFed story no one is tellingJ.P. Morgan's Private Bank quietly advised 333 billionaire families to move 60% of their portfolios into alter...TradeSmith | SponsoredOne page of the SpaceX S-1 will move this stock overnightWhen SpaceX files its S-1 in June, the SEC will require full disclosure of operating expenses - including powe...Behind the Markets | SponsoredThe Death of the Nasdaq?The Death of the Nasdaq? Wall Street legend Marc Chaikin's award-winning system turned bearish on software ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elanco Animal Health Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Elanco Animal Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
